{
    "root": "255faee4-9699-426d-a720-b500236fb6cb",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Propranolol hydrochloride",
    "value": "20250313",
    "ingredients": [
        {
            "name": "PROPRANOLOL HYDROCHLORIDE",
            "code": "F8A3652H1V"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "FD&C YELLOW NO. 6",
            "code": "H77VEI93A8"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        }
    ],
    "indications": null,
    "contraindications": null,
    "warningsAndPrecautions": "Propranolol Hydrochloride Tablets, USP 80 mg – Yellow, round biconvex scored tablets with “I” “161” on one side and other side plain. \n                  NDC: 71335-2594-5: 10 Tablets in a BOTTLE\n                  NDC: 71335-2594-1: 30 Tablets in a BOTTLE\n                  NDC: 71335-2594-2: 100 Tablets in a BOTTLE\n                  NDC: 71335-2594-3: 90 Tablets in a BOTTLE\n                  NDC: 71335-2594-4: 60 Tablets in a BOTTLE\n                  \n                  Repackaged/Relabeled by:Bryant Ranch Prepack, Inc.Burbank, CA 91504",
    "adverseReactions": "Propranolol is contraindicated in 1) cardiogenic shock; 2) sinus bradycardia and greater than first degree block; 3) bronchial asthma; and 4) in patients with known hypersensitivity to propranolol hydrochloride."
}